Publication
Personal dose equivalent HP(10) in patient’s family members after 131I therapy in thyroid cancer and benign thyroid diseases
dc.contributor.author | Raminhas Carapinha, Maria João | |
dc.contributor.author | Ferreira, T. C. | |
dc.contributor.author | Rézio, M. T. | |
dc.contributor.author | Salgado, L. | |
dc.contributor.author | Vaz, S. | |
dc.contributor.author | Costa, G. | |
dc.contributor.author | Ferreira, R. | |
dc.contributor.author | Isidoro, J. | |
dc.contributor.author | Nunes, Carla | |
dc.contributor.author | Tavares, A. | |
dc.date.accessioned | 2019-11-26T17:14:29Z | |
dc.date.available | 2019-11-26T17:14:29Z | |
dc.date.issued | 2019-10 | |
dc.description.abstract | Aim of the study - The aim is to quantify the personal equivalent dose Hp(10) of the family members (FMs) of patients submitted to iodine-131 therapy (RAIT): thyroid cancer (TC) or benign thyroid diseases (BTD) and compare Hp(10) values of children and adults. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | Carapinha MJ, Ferreira TC, Rézio MT, Salgado L, Vaz S, Costa G, et al. Personal dose equivalent HP(10) in patient’s family members after 131I therapy in thyroid cancer and benign thyroid diseases. In: EANM’19 – Annual Congress of the European Association of Nuclear Medicine, Barcelona (Spain), October 12-16, 2019. Eur J Nucl Med Mol Imaging. 2019;46 Suppl 1:S838-9. | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.21/10749 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Springer | pt_PT |
dc.relation.publisherversion | https://link.springer.com/article/10.1007/s00259-019-04486-2 | pt_PT |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | pt_PT |
dc.subject | Nuclear medicine | pt_PT |
dc.subject | Iodine-131 | pt_PT |
dc.subject | Thyroid cancer | pt_PT |
dc.subject | Benign thyroid disease | pt_PT |
dc.subject | Dosimetry | pt_PT |
dc.title | Personal dose equivalent HP(10) in patient’s family members after 131I therapy in thyroid cancer and benign thyroid diseases | pt_PT |
dc.type | conference object | |
dspace.entity.type | Publication | |
oaire.citation.endPage | S839 | pt_PT |
oaire.citation.issue | Suppl 1 | pt_PT |
oaire.citation.startPage | S838 | pt_PT |
oaire.citation.title | European Journal of Nuclear Medicine and Molecular Imaging | pt_PT |
oaire.citation.volume | 46 | pt_PT |
person.familyName | Raminhas Carapinha | |
person.givenName | Maria João | |
person.identifier.ciencia-id | F416-6BAA-D4D7 | |
person.identifier.orcid | 0000-0002-3343-6500 | |
person.identifier.rid | Z-1221-2018 | |
rcaap.rights | openAccess | pt_PT |
rcaap.type | conferenceObject | pt_PT |
relation.isAuthorOfPublication | 406de1e9-dae8-488d-bcdc-fef1da6526a1 | |
relation.isAuthorOfPublication.latestForDiscovery | 406de1e9-dae8-488d-bcdc-fef1da6526a1 |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- Personal dose equivalent HP(10) in patient’s family members after 131I therapy in thyroid cancer and benign thyroid diseases.pdf
- Size:
- 72.55 KB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: